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a b s t r a c t 
Cerebral small vessel disease (SVD) is a leading cause of vascular cognitive impairment, however the pre- 
cise nature of SVD-related cognitive deficits, and their associations with structural brain changes, remain 
unclear. We combined computational volumes and visually-rated MRI markers of SVD to quantify total 
SVD burden, using data from the Lothian Birth Cohort 1936 (n = 540; age: 72.6 ± 0.7 years). We found 
negative associations between total SVD burden and general cognitive ability (standardized β: -0.363; 
95%CI: [-0.49, -0.23]; p (FDR) < 0.001), processing speed (-0.371 [-0.50, -0.24]; p (FDR) < 0.001), verbal mem- 
ory (-0.265; [-0.42, -0.11]; p (FDR) = 0.002), and visuospatial ability (-0.170; [-0.32, -0.02]; p (FDR) = 0.029). 
Only the association between SVD burden and processing speed remained after accounting for covariance 
with general cognitive ability (-0.325; [-0.61, -0.04]; p (FDR) = 0.029). This suggests that SVD’s association 
with poorer processing speed is not driven by, but is independent of its association with poorer general 
cognitive ability. Tests of processing speed may be particularly sensitive to the cognitive impact of SVD, 
but all major cognitive domains should be tested to determine the full range of SVD-related cognitive 
characteristics. 
© 2021 The Author(s). Published by Elsevier Inc. 

















Cerebral small vessel disease (SVD) is a leading cause of vas-
cular cognitive impairment, contributing to multiple neurological
disorders ranging from stroke, to mild cognitive impairment and
dementia. Whereas current neuroimaging methods lack the spatial
resolution to visualize the brain’s small vessels, the downstream
impact of their dysfunction is visible on brain imaging as white
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https://doi.org/10.1016/j.neurobiolaging.2021.04.007 origin, visible perivascular spaces (PVS) and cerebral microbleeds
( Wardlaw et al., 2019 ). The presence and progression of radiolog-
ical markers of SVD are frequently used as outcome measures in
trials of interventions and treatments for SVD, however, the na-
ture and extent of their associations with domain-specific cognitive
outcomes remains unclear. 
The majority of the literature examining SVD-related brain
changes and cognitive ability focuses on individual radiological
markers of SVD (most commonly WMH volume), thus fails to ac-
count for their potentially cumulative impact on cognitive perfor-
mance. There is evidential support for considering the ‘total’ bur-
den of SVD as a variable: different types of SVD lesions commonly
occur together, are aetiologically related ( Wardlaw et al., 2013 ), and
associate with one another across a range of patient and healthy
ageing populations ( Ghaznawi et al., 2019 , Potter et al., 2015 ). In
recent years, studies have quantified the total burden of SVD with
a 0-4 score, which allocates one point for the presence of WMH,n open access article under the CC BY license 

















































































































PVS, lacunes or microbleeds ( Al Olama et al., 2020 , Banerjee et al.,
2018 , Del Brutto et al., 2018 , Huijts et al., 2013 , Uiterwijk et al.,
2016 ). Whereas the 0-4 score can be calculated quickly from vi-
sual inspection of a brain scan, it lacks sensitivity to the range
or severity of the individual SVD markers. To increase the fidelity
of SVD burden quantification, two recent studies have developed
continuous total SVD scores ( Jokinen et al., 2020 , Staals et al.,
2015 ), finding negative associations between the continuous SVD
burden score and domain-specific cognitive abilities. These stud-
ies also found that the magnitude of these associations surpassed
those of models using a simple 0-4 SVD burden score ( Staals et al.,
2015 ), or individual MRI markers of SVD ( Jokinen et al., 2020 ), as
predictors of cognitive performance. However, research on cogni-
tive ageing has established that age-related cognitive decline is not
only observed across different domains of cognitive ability, but is
shared between them, owing to an overall decline in general cog-
nitive ability ( Salthouse, 2010 , Tucker-Drob et al., 2019 ). A key out-
standing question, therefore, is whether poor performance in cer-
tain cognitive domains is associated with general cognitive decline,
or whether SVD has additional independent associations with spe-
cific domains of cognitive ability. 
In this study, we extend the work of Staals and colleagues
( 2015 ) by constructing a variable representing the total MRI-visible
burden of SVD. We use structural equation modelling (SEM) to
combine continuous computational measures of WMH and PVS, as
opposed to previous studies that have employed ordinal measures
derived from visual rating scales. We test whether the inclusion of
these continuous SVD markers increases the sensitivity of the SVD
score in its associations with general and domain-specific cogni-
tive abilities. We then test whether poor performance in certain
cognitive domains is associated with general cognitive decline, or
whether SVD has additional independent associations with specific
domains of cognitive ability. By gaining insight into the nature of
the associations between the total brain burden of SVD and cog-
nitive abilities, we aim to better characterize SVD-related cognitive
impairment and facilitate its accurate measurement in trials and in
clinical management. 
2. Materials and methods 
2.1. Study cohort 
Participants were members of the Lothian Birth Cohort 1936
(LBC1936), which has been described previously ( Taylor et al.,
2018 ). Briefly, the LBC1936 is a longitudinal follow-up to the Scot-
tish Mental Survey of 1947, which assessed the cognitive ability
of 70,805 11-year-old children, who were born in 1936 and were
attending school in Scotland ( Scottish Council for Research in Ed-
ucation, 1949 ). The present study includes participants from Wave
2 of the study, the first wave at which neuroimaging was carried
out (usable neuroimaging data were available for n = 680). Vis-
ible PVS are extremely small on neuroimaging ( ≤3 mm), there-
fore their computational detection is highly sensitive to noise and
motion artefacts. Because of this, quality requirements for the MR
images used in this study were high and images for 140 partic-
ipants with available neuroimaging data could not be processed
through the PVS pipeline ( Ballerini et al., 2020 ). Reasons for this
were failed registration of the centrum semiovale, noise or motion
artefacts (which can have a similar appearance to PVS), or where
small WMH were misclassified as PVS ( Ballerini et al., 2020 ). Lack
of computational PVS segmentation was the only factor that pre-
vented inclusion in the study, thus the remaining 540 participants
constitute our final sample. Approval for the LBC1936 was ob-
tained from the Scotland A Research Ethics Committee for Scotland
(07/MRE00/58). All participants gave written, informed consent. 2.2. MRI acquisition and radiological markers of SVD 
Details of the MRI acquisition protocol have been pub-
lished previously ( Wardlaw et al., 2011 ). Briefly, participants were
scanned using a GE Signa Horizon HDx 1.5 Tesla clinical scan-
ner (General Electric, Milwaukee, WI) operating in ‘research mode’,
equipped with a self-shielding gradient set (33 mT/m maxi-
mum gradient strength) and manufacturer supplied eight-channel
phased-array head coil. Sequences acquired were T1-weighted
(T1W), T2-weighted (T2W), T2 ∗-weighted (T2 ∗W) and fluid atten-
uated inversion recovery-weighted (FLAIR) images. MRI markers
of SVD (WMH, PVS, lacunes and microbleeds) were measured us-
ing a combination of computational and visual rating methods,
all performed blind to clinical and cognitive data (see Table 1 ;
Wardlaw et al., 2011 , 2013 ). In all analyses we divide WMH vol-
ume by total intracranial volume (TIV) to account for differences
in head size. 
2.3. Cognitive data 
Participants completed the Moray House Test No.12, a test
of general intelligence, at the age of 11 as part of the Scottish
Mental Survey of 1947 ( Scottish Council for Research in Educa-
tion, 1949 ). In later life, participants completed a comprehensive
battery of cognitive tests as part of the LBC1936, which we have
grouped into three domains (processing speed, verbal memory, and
visuospatial ability) according to prior work characterizing their
correlational structure ( Tucker-Drob et al., 2014 ). The domain of
processing speed includes Digit Symbol Substitution and Symbol
Search from the Wechsler Adult Intelligence Scale-III (WAIS-III UK ;
Wechsler, 1998a ) and two experimental tasks: Four Choice Reac-
tion Time ( Deary et al., 2001 ) and Inspection Time ( Deary et al.,
2004 ). Four Choice Reaction Time scores were multiplied by -
1, so that higher scores indicated better performance. The do-
main of verbal memory includes Verbal Paired Associates (total
score) and Logical Memory from the Wechsler Memory Scale III UK
(WMS-III UK ; Wechsler, 1998b ), and Digit Span (WAIS-III UK ). Vi-
suospatial ability includes Block Design, Matrix Reasoning (both
WAIS-III UK ) and Spatial Span (average of forwards and backwards;
WMS-III UK ). Scores on the ten cognitive tests included in these do-
mains were considered together as an indicator of general cog-
nitive ability, given the well-replicated shared covariances of test
scores across domains ( Deary et al., 2010 ; a correlation matrix of
cognitve test scores is provided in Table S1). 
2.4. Covariates 
Cognitive and neuroimaging data were acquired on two sepa-
rate occasions. To account for variation in time intervals between
these two occasions across the cohort, we adjusted the manifest
cognitive variables for the difference in days between imaging and
cognitive data acquisition, outside of the SEM models (residual-
ized using linear regression). We included age in years at the time
of MRI, sex, vascular risk (see below), the depression sub-score
from the Hospital Anxiety and Depression Scale (HADS-D), and
Moray House Test score at age 11 (subsequently referred to as
age-11 IQ) as covariates, in a stepwise manner, in all of our mod-
els. Vascular risk variables included self-reported history of hy-
pertension (yes/no), diabetes mellitus (yes/no), and smoking status
(ever/never); blood-derived glycated hemoglobin (% total HbA1c);
blood-derived total cholesterol (mmol/l); and systolic and dias-
tolic blood pressure (average of six readings: three seated and
three standing), which were measured by trained nurses. We used
confirmatory factor analysis (CFA) to construct a latent variable
representing vascular risk, as previously modelled in this cohort
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Table 1 
Definitions of key imaging features of SVD on structural MRI 




Visual rating: Periventricular and deep WMH were rated on the Fazekas scale (range 0–3) using FLAIR- 
and T2-weighted sequences ( Fazekas et al., 1987 ). 
Computational volume: WMH and total intracranial volumes (TIV) were measured using MCMxxVI 
( Valdés Hernández et al., 2010 ), a validated multispectral image processing method that combines T2, 
T2 ∗W and FLAIR sequences for segmentation. All slices of all scans were checked by a trained observer 
and manually corrected, if necessary, to ensure that no true WMH had been omitted and to avoid 
including erroneous tissues in the WMH. 
Visible perivascular 
spaces (PVS) 
Visual rating: PVS in the basal ganglia were quantified using a previously described visual rating scale 
( Doubal et al., 2010 ) and were defined as small punctate or linear hyperintensities, in axial and 
longitudinal section respectively, on T2W that are < 3 mm in diameter. Larger PVS may be visible on 
T1W as decreased signal, but not visible on T2W or FLAIR ( Wardlaw et al., 2011 , 2013 ). 
Computational count: PVS were computationally segmented in the native T2W space in the centrum 
semiovale using a recently validated technique ( Ballerini et al., 2018 , 2020 ) and are presented as total 
number of PVS. After segmentation of the PVS, all binary PVS masks (superimposed on T2-weighted 
images) were visually checked for the accurate quantification of PVS by a trained operator and were 
accepted or rejected blind to all other data. Where ambiguity arose, FLAIR and T1-weighted sequences 
were also checked ( Ballerini et al., 2020 ). 
Lacunes Lacunes were classified as being present or absent and were defined as small ( > 3 mm and < 2 cm in 
diameter) subcortical lesions of CSF-equivalent signal on T2W and decreased signal on T1W and FLAIR 
images in the white matter, basal ganglia, and brainstem ( Wardlaw et al., 2011 , 2013 ). 
Cerebral microbleeds Cerebral microbleeds were classified as being present or absent and were defined as small ( < 5 mm), 
homogenous, round foci of low signal intensity on T2 ∗W images in the white matter, basal ganglia, 
brain stem, cerebellum, and cortico-subcortical junction ( Wardlaw et al., 2011 , 2013 ). 
Note: Visual ratings were made by an experienced, registered neuroradiologist and a random 20% sample and any uncertain cases were independently checked by a second 

































































( Wardlaw et al., 2014 ), and extracted its factor score for inclusion
as a covariate. 
2.5. Statistical analysis 
2.5.1. Measurement models 
We used CFA to construct a computationally-derived latent vari-
able representing the total MRI-visible burden of SVD. This CFA
assumed that the covariance among its indicators (WMH vol-
ume/TIV, PVS, lacunes, and microbleeds) was due to a single un-
derlying factor (SVD), which is separate from unique and error
variance in the four contributing variables. WMH volume/TIV and
centrum semiovale PVS count were continuous computationally-
derived variables, and lacunes and microbleeds were binary vari-
ables (i.e., present/absent), derived from visual assessment. 
We also used CFA to reconstruct the latent total SVD variable
based on ordinal visual scores used by Staals et al. (2015) , which
included deep and periventricular Fazekas scores as measures of
WMH (both range 0–3), a visual rating scale for the assessment
of PVS in the basal ganglia (range 0–4; Doubal et al., 2010 ), and
counts of cerebral microbleeds and lacunes, which we converted
to binary variables (present/absent) due to the low frequency of
values greater than one. 
2.5.2. Multivariable SEM models 
First, we specified separate linear regressions between the
computationally-derived SVD burden variable (independent vari-
able) and latent variables of general cognitive ability, process-
ing speed, verbal memory, and visuospatial ability. These models
tested associations between total SVD burden and each of the la-
tent cognitive variables separately. We included age, sex, vascular
risk (extracted factor score), HADS-D score, and age-11 IQ as co-
variates in a step-wise manner to assess their impact on any as-
sociations. Covariates were free to correlate with one another and
with total SVD burden, and were also regressed on the cognitive
factor. To assess the extent to which these associations might be
driven by the contribution of WMH to the SVD burden score, we
also ran these models with WMH/TIV as the predictor and com-pared the effect size magnitudes from both sets of models us-
ing the Williams test ( Williams, 1959 ), implemented in the cocor
package ( Diedenhofen and Musch, 2015 ) in R version 4.0.1 ( R Core
Team, 2020 ). 
Next, we re-ran these analyses using the reconstructed total
SVD variable as created by Staals et al. (2015) as the predictor. We
compared the effect size magnitudes of these models with those
of models including the computationally-derived SVD variable as a
predictor, again using the Williams test. 
General cognitive ability accounts for approximately 40% of the
variability in performance on diverse batteries of cognitive tests
( Carroll, 1993 ). Thus, given that cognitive domains are all substan-
tially and positively correlated, in order to generate a domain-
specific cognitive score, one must account for its covariance with
other cognitive domains (i.e., general cognitive ability). To account
for the confounding effects of general cognitive ability, we next
tested associations between the computationally-derived SVD bur-
den variable and a bifactor model of general cognitive ability
( Fig. 1 ), which partitions variance in the cognitive test scores into
that which contributes to general cognitive ability, and that which
uniquely contributes to the domain-specific factors. The results of
this model will indicate whether total SVD burden associates with
any of the domain-specific cognitive scores independently of the
variance that the domain-specific scores share (i.e., general cog-
nitive ability). In this model we included age, sex, vascular risk
HADS-D score, and age-11 IQ simultaneously as covariates. 
The estimator for all multivariable SEM analyses was weighted
least square mean and variance adjusted (WLSMV), which does not
make distributional assumptions about observed variables. WLSMV
uses logit link for continuous, and probit link for categorical vari-
ables. Model fit was assessed using four absolute fit indices: Root
Mean Square Error of Approximation (RMSEA; < 0.06 considered
acceptable), Comparative Fit Index (CFI; > 0.95 acceptable), Tucker-
Lewis Index (TLI; > 0.95 acceptable), and Standardized Root Mean
Square Residual (SRMR; < 0.08 acceptable). Pairwise present data
were analyzed due to the small amount of missing data (all cog-
nitive variables had n ≥530). Data were analyzed in MPlus version
8.3 ( Muthén and Muthén, 1998-2017 ). We corrected p -values for
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Fig.1. Diagram illustrating a bifactor model of general cognitive ability. Note: Following conventional SEM notation, variables in squares were observed and measured, and 



















































multiple comparisons using the False Discovery Rate adjustment
(FDR; Benjamini and Hochberg, 1995 ) with the p.adjust function in
R version 4.0.1 ( R Core Team, 2020 ). 
2.6. Data availability 
Data supporting this study are available upon reasonable re-
quest from the corresponding authors. 
3. Results 
3.1. Participant characteristics and SVD burden quantification 
Characteristics of the study participants are presented in
Table 2 . The four MRI markers of SVD loaded significantly onto
the computationally-derived SVD burden variable ( Fig. 2 ) and
the model fitted well (RMSEA = 0.00; CFI = 1.00; TLI = 1.02;
SRMR = 0.019; a correlation matrix of the SVD marker variables
is provided in Table S2). The four marker variables had moderate
to large loadings on the latent SVD variable, which accounted for
25% of the variance in WMH/TIV, 10% of the variance in PVS, 32%
of the variance in lacunes, and 18% of the variance in microbleeds.
3.2. Computationally-derived SVD burden score associates negatively 
with all cognitive domains 
Total SVD burden demonstrated negative associations with
all cognitive domains ( Table 3 ). These associations remained
significant after the inclusion of age, sex, vascular risk, HADS-D
score, and age-11 IQ as covariates; covariate-adjusted absolute ef-
fect sizes range from -0.17 to -0.37. The latent variable represent-
ing total SVD burden accounted for 13% of the variance in gen-
eral cognitive ability, 14% of the variance in processing speed, 7%
of the variance in verbal memory, and 3% of the variance in vi-
suospatial ability. Williams tests indicated that the magnitudes of
these models (including all covariates) were significantly greaterthan those specifying WMH/TIV as the predictor: general cognitive
ability (Williams’ one-sided t- value = -7.38; p < 0.001), process-
ing speed ( t = -7.28; p < 0.001); verbal memory ( t = -5.06; p <
0.001), visuospatial ability ( t = -2.81; p = 0.005). Results of asso-
ciations between WMH/TIV and cognitive factors are presented in
Table S3. 
Similarly, the reconstructed total SVD burden variable used by
Staals et al. (2015) associated negatively with all cognitive do-
mains ( Table 4 ). Williams tests indicated that the magnitudes of
these models (including all covariates) were significantly smaller
than those using the computationally-derived SVD burden variable
as the predictor: general cognitive ability (Williams’ one-sided t-
value = -6.25; p < 0.001), processing speed ( t = -6.11; p < 0.001);
verbal memory ( t = -4.48; p < 0.001), visuospatial ability ( t = -
2.51; p = 0.012). 
3.3. Computationally-derived SVD burden score shows a specific and 
independent association with processing speed 
The multivariable bifactor model, performed to test associa-
tions between the computationally-derived SVD burden score and
domain-specific cognitive abilities independently of general cog-
nitive ability, fitted well ( Fig. 3 ; RMSEA = 0.030; CFI = 0.970;
TLI = 0.952; SRMR = 0.044). Total SVD burden was negatively
associated with general cognitive ability (standardized β: -0.224;
95%CI: [-0.40, -0.05]; p (FDR) = 0.016) and processing speed (-
0.325; [-0.61, -0.04], p (FDR) = 0.029), and accounted for 5% of
the variance in general cognitive ability and 11% of the variance
in residual processing speed. There were no significant associa-
tions between total SVD burden and verbal memory (-0.133, [-0.32,
0.05], p (FDR) = 0.166) or visuospatial ability (0.075; [-0.25, 0.40],
p (FDR) = 0.654). The latter result may be due to the heavy loading
of the visuospatial tests onto general cognitive ability, which left
relatively little variance for the independent visuospatial factor. 
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Table 2 
Characteristics of the study cohort 
N Mean (SD) unless otherwise stated 
Sociodemographic 
Age, y 540 72.6 (0.7) 
Female, n (%) 540 252 (46.7%) 
Education, y 540 10.9 (1.2) 
Vascular risk 
Hypertension history, n (%) 540 259 (48.0%) 
Systolic blood pressure, mm Hg 534 146.5 (18.0) 
Diastolic blood pressure, mm Hg 534 79.7 (18.0) 
Diabetes history, n (%) 540 54 (10.0%) 
HbA1c % total 518 5.7 (0.6) 
Cholesterol, mmol/l 521 5.2 (1.1) 
CVD history, n (%) 540 154 (28.5%) 
Smoking status, n (%) 540 Ever = 274 (50.7%); Never = 266 (49.3%) 
Neurological/psychiatric 
Self-reported dementia, n (%) 540 0 (0%) 
Self-reported stroke, n (%) 534 37 (10.5%) 
HADS-D score 540 2.5 (2.1) 
Neuroimaging 
Total WMH volume/TIV 536 0.008 (0.009) 
PVS count 540 258.7 (94.6) 
Lacunes, n (%) 540 Present = 28 (5.1%); Absent = 512 (94.9%) 
Microbleeds, n (%) 540 Present = 65 (12.0%); Absent = 475 (88.0%) 
Cognitive 
Moray House Test score age-11(max. 76) 511 50.2 (11.9) 
Note. CVD, Cardiovascular disease; HADS-D, depression sub-score of the Hospital Anxiety and Depression Scale; PVS, visible perivascular spaces; TIV, total intracranial 
volume; WMH, white matter hyperintensities of presumed vascular origin. 
Fig. 2. CFA diagram of latent variable representing total MRI-visible SVD burden. Note: Model estimator: WLSMV; RMSEA = 0.00; CFI = 1.00; TLI = 1.02; SRMR = 0.019. 
All indicators loaded significantly onto the factor at p < 0.001. Values are standardized estimates with standard errors in parentheses. For continuous variables (WMH and 
PVS) factor loadings represent standardized linear regression coefficients. For the binary variables (lacunes and microbleeds) factor loadings represent standardized probit 
regression coefficients. Factor loadings were freed for their interpretation. Following conventional SEM notation, variables in squares were observed and measured, and 
variables in circles represent unmeasured latent variables. Single headed arrows represent a relationship between two variables – in this model, this is either a linear or 
probit regression, with the arrow pointing towards the dependent variable. 
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Table 3 
Associations between the computationally-derived total SVD burden variable and cognitive domains 
Standardized β (SE) 95% CI Uncorrected p value FDR corrected p value RMSEA CFI TLI SRMR 
General cognitive ability -0.438 (0.08) -0.595, -0.282 < 0.001 < 0.001 0.031 0.971 0.962 0.039 
+ age -0.467 (0.09) -0.647, -0.287 < 0.001 < 0.001 0.028 0.974 0.966 0.038 
+ age + sex -0.467 (0.09) -0.647, -0.287 < 0.001 < 0.001 0.054 0.895 0.867 0.051 
+ age + sex + vascular risk -0.459 (0.09) -0.639, -0.279 < 0.001 < 0.001 0.057 0.871 0.837 0.053 
+ age + sex + vascular risk + depression -0.407 (0.08) -0.569, -0.245 < 0.001 < 0.001 0.054 0.879 0.846 0.052 
+ age + sex + vascular risk + depression + age-11 IQ -0.363 (0.07) -0.493, -0.233 < 0.001 < 0.001 0.056 0.873 0.836 0.052 
Processing speed -0.442 (0.08) -0.589, -0.296 < 0.001 < 0.001 0.024 0.991 0.987 0.031 
+ age -0.430 (0.08) -0.587, -0.273 < 0.001 < 0.001 0.013 0.997 0.995 0.029 
+ age + sex -0.426 (0.08) -0.581, -0.272 < 0.001 < 0.001 0.053 0.933 0.903 0.043 
+ age + sex + vascular risk -0.455 (0.08) -0.619, -0.291 < 0.001 < 0.001 0.050 0.933 0.901 0.043 
+ age + sex + vascular risk + depression -0.443 (0.08) -0.601, -0.284 < 0.001 < 0.001 0.046 0.940 0.908 0.041 
+ age + sex + vascular risk + depression + age-11 IQ -0.371 (0.07) -0.502, -0.240 < 0.001 < 0.001 0.046 0.940 0.905 0.040 
Verbal memory -0.329 (0.09) -0.498, -0.160 < 0.001 < 0.001 0.000 1.000 1.000 0.026 
+ age -0.318 (0.09) -0.496, -0.139 < 0.001 < 0.001 0.000 1.000 1.000 0.027 
+ age + sex -0.310 (0.09) -0.485, -0.136 < 0.001 < 0.001 0.035 0.949 0.921 0.039 
+ age + sex + vascular risk -0.331 (0.09) -0.511, -0.151 < 0.001 < 0.001 0.031 0.955 0.927 0.039 
+ age + sex + vascular risk + depression -0.324 (0.09) -0.505, -0.143 < 0.001 < 0.001 0.029 0.959 0.931 0.038 
+ age + sex + vascular risk + depression + age-11 IQ -0.265 (0.08) -0.418, -0.112 0.001 0.002 0.031 0.962 0.934 0.038 
Visuospatial ability -0.247 (0.08) -0.412, -0.081 0.003 0.004 0.000 1.000 1.000 0.027 
+ age -0.221 (0.09) -0.399, -0.043 0.015 0.018 0.000 1.000 1.000 0.026 
+ age + sex -0.231 (0.09) -0.410, -0.052 0.011 0.015 0.031 0.966 0.947 0.037 
+ age + sex + vascular risk -0.226 (0.09) -0.407, -0.044 0.015 0.018 0.028 0.968 0.949 0.037 
+ age + sex + vascular risk + depression -0.215 (0.09) -0.393, -0.036 0.018 0.021 0.025 0.972 0.954 0.036 
+ age + sex + vascular risk + depression + age-11 IQ -0.170 (0.08) -0.319, -0.020 0.026 0.029 0.022 0.982 0.968 0.034 
Note. N = 540 for all analyses . After the inclusion of sex as a covariate in the models, the TLI and/or CFI fell below conventional thresholds (both > 0.95). Off-diagonal values 
of the residual correlation matrix indicated that there were correlations between sex and the residuals of several manifest cognitive variables, which were unaccounted for in 
our model. When we specified regressions between sex and these residuals, the TLI and CFI reached acceptable levels. Combined with the good fit of our initial measurement 
models, this indicates that the lower CFI and TLI values of these models are due to unspecified correlations between sex and cognitive variables and are not due to model 
mis-specification. CFI, comparative fit index; RMSEA, root mean square error of approximation; SRMR, standardized root mean square residual; TLI, Tucker Lewis index. 
Table 4 
Associations between the reconstructed SVD burden variable used by Staals et al. and cognitive domains 
Standardized β (SE) 95% CI Uncorrected p value FDR corrected p value RMSEA CFI TLI SRMR 
General cognitive ability -0.254 (0.05) -0.360, -0.148 < 0.001 < 0.001 0.032 0.970 0.962 0.045 
+ age -0.242 (0.05) -0.348, -0.135 < 0.001 < 0.001 0.030 0.969 0.961 0.046 
+ age + sex -0.244 (0.05) -0.350, -0.139 < 0.001 < 0.001 0.048 0.915 0.893 0.054 
+ age + sex + vascular risk -0.236 (0.05) -0.341, -0.130 < 0.001 < 0.001 0.051 0.895 0.869 0.056 
+ age + sex + vascular risk + depression -0.230 (0.05) -0.332, -0.128 < 0.001 < 0.001 0.049 0.899 0.873 0.054 
+ age + sex + vascular risk + depression + age-11 IQ -0.202 (0.04) -0.286, -0.117 < 0.001 < 0.001 0.051 0.892 0.864 0.055 
Processing speed -0.263 (0.05) -0.398, -0.159 < 0.001 < 0.001 0.034 0.981 0.973 0.045 
+ age -0.251 (0.05) -0.355, -0.146 < 0.001 < 0.001 0.034 0.977 0.969 0.048 
+ age + sex -0.257 (0.05) -0.358, -0.156 < 0.001 < 0.001 0.047 0.950 0.931 0.051 
+ age + sex + vascular risk -0.245 (0.05) -0.347, -0.144 < 0.001 < 0.001 0.044 0.951 0.932 0.050 
+ age + sex + vascular risk + depression -0.239 (0.05) -0.337, -0.141 < 0.001 < 0.001 0.040 0.954 0.934 0.048 
+ age + sex + vascular risk + depression + age-11 IQ -0.214 (0.05) -0.304, -0.124 < 0.001 < 0.001 0.041 0.952 0.928 0.048 
Verbal memory -0.171 (0.06) -0.293, -0.050 0.006 0.008 0.000 1.000 1.000 0.038 
+ age -0.167 (0.06) -0.289, -0.045 0.007 0.008 0.021 0.989 0.984 0.044 
+ age + sex -0.180 (0.06) -0.297, -0.063 0.003 0.005 0.030 0.975 0.963 0.046 
+ age + sex + vascular risk -0.179 (0.06) -0.297, -0.062 0.003 0.005 0.027 0.976 0.964 0.045 
+ age + sex + vascular risk + depression -0.177 (0.06) -0.295, -0.060 0.003 0.005 0.026 0.974 0.960 0.045 
+ age + sex + vascular risk + depression + age-11 IQ -0.145 (0.05) -0.248, -0.042 0.006 0.008 0.029 0.971 0.953 0.044 
Visuospatial ability -0.163 (0.05) -0.269, -0.056 0.003 0.005 0.000 1.000 1.000 0.034 
+ age -0.152 (0.06) -0.259, -0.045 0.005 0.007 0.010 0.998 0.997 0.040 
+ age + sex -0.139 (0.06) -0.247, -0.030 0.013 0.015 0.021 0.988 0.984 0.042 
+ age + sex + vascular risk -0.131 (0.06) -0.241, -0.022 0.019 0.021 0.019 0.990 0.985 0.042 
+ age + sex + vascular risk + depression -0.127 (0.06) -0.235, -0.019 0.021 0.022 0.018 0.989 0.983 0.042 
+ age + sex + vascular risk + depression + age-11 IQ -0.101 (0.05) -0.194, -0.008 0.034 0.034 0.017 0.991 0.985 0.040 
Note. N = 540 for all analyses . 
















To date, the majority of studies have used individual MRI mark-
ers of SVD, or a simple 0-4 sum score to quantify SVD burden. In
this study of 540 community-dwelling older adults, we combined
computational and visually-rated MRI markers of SVD (including
for the first time, a continuous measure of PVS) to estimate a con-
tinuous latent variable representing total MRI-visible SVD burden.In doing so, we were able to increase the fidelity with which SVD
burden is quantified, relative to a previous method which relied
on visually-rated SVD markers only ( Staals et al., 2015 ). The re-
sults of our analyses indicated that a higher SVD burden was not
only associated with poorer general cognitive ability and process-
ing speed, as current consensus statements suggest ( Peng, 2019 ,
Rosenberg et al., 2016 ), but also with poorer memory and visu-
ospatial ability. We then accounted for the covariance between
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Fig. 3. SEM diagram illustrating associations between SVD burden and a bifactor model of general cognitive ability. Note:. Model estimator: WLSMV. Fit indices: RM- 
SEA = 0.030; CFI = 0.970; TLI = 0.952; SRMR = 0.044. Solid black lines between total SVD burden and cognitive factors represent significant associations and dashed lines 
represent non-significant associations after FDR correction. Factor loadings are standardized linear regression coefficients and standard errors are shown in parentheses. Age 

































cognitive domain scores and general cognitive ability in a bifactor
model, finding that total SVD burden was associated with process-
ing speed not only due to, but in addition to its association with
poorer general cognitive ability. A comparison of the covariate-
adjusted effect sizes for associations between total SVD burden
and processing speed before accounting for general cognitive abil-
ity (simple regression model standardized β: -0.371) and after ac-
counting for general cognitive ability (bifactor model standardized
β: -0.325), suggests that approximately 12% of the variance in pro-
cessing speed is accounted for by general ability. Therefore, failing
to account for covariance with general cognitive ability could lead
to an overestimation of effect sizes between SVD burden and pro-
cessing speed. 
Slowed processing speed and poor executive function are often
considered to be the hallmark cognitive features of SVD, with lit-
tle attention given to other cognitive domains. However, our results
suggest that alongside slowed processing speed, SVD burden is alsorelated to poorer performance on tests of memory and visuospa-
tial ability, even in a cohort of individuals with mild, non-clinical
presentations of SVD. We found associations between SVD burden
and verbal memory and visuospatial ability in separate regression
models, but not in the bifactor model. This suggests that negative
associations between SVD and both memory and visuospatial abil-
ity may be a consequence of the negative association between SVD
and general cognitive ability. It has been suggested that poor per-
formance on tests of memory and visuospatial ability (two cogni-
tive abilities subtended by specific cortical areas) could result from
the disruption of white matter connections between cortical and
subcortical regions ( Tuladhar et al., 2015 ). Our data support this
notion and suggest that damage to these connections may be part
of a more general, diffuse process. 
Whereas slowed information processing speed is recognized as
a key feature of SVD, processing speed test scores are a chimera;
that is, part of the variation in processing speed is due to its





























































































































association with general cognitive ability. Therefore, it was pre-
viously unknown whether the apparent association between SVD
and slowed processing speed was due to SVDs impact on gen-
eral cognitive ability, or whether SVD may have specific and in-
dependent effects on processing speed. Here, we have removed
the general cognitive ability variance from processing speed (and
other cognitive domains), which affords a better test of any SVD-
processing speed association. Our results suggested that the asso-
ciation between SVD burden and processing speed was indepen-
dent of general cognitive ability, thus favoring the latter hypothe-
sis. To the best of our knowledge, this is the first study to demon-
strate an association between SVD burden and processing speed
independently of the shared variance between cognitive test
scores, which acts as a confound. Typically, this confound remains
unaccounted for, thus previous studies that have reported asso-
ciations between SVD and scores from tests of processing speed
could be misleading. Processing speed is often regarded as hav-
ing a special status among the domains of cognitive ability; it
is typically the first domain affected by age, and as performance
on tasks in a variety of cognitive domains relies on information
processing, its early decline may lead changes in other domains
( Finkel et al., 2007 ). It follows that networks supporting processing
speed appear to be distributed throughout the brain: previously
in the LBC1936, poorer processing speed was associated with age-
related reductions in white matter microstructural integrity across
the whole brain, and in broad regions of interest ( Deary et al.,
2006 , Kuznetsova et al., 2016 , Penke et al., 2010 ). That total SVD
burden may have a specific impact on processing speed, inde-
pendent of its effect on general cognitive ability, further suggests
that SVD-related brain changes are widespread, rather than tract-
specific. 
Previously, in 680 participants from the LBC1936
Staals et al. (2015) found no associations between their total
SVD burden score (derived from visual rating scales of individ-
ual MRI markers of SVD) and a composite score of processing
speed. This composite score of processing speed was extracted
from a bifactor model of general cognitive ability, so as in our
study, was independent of general cognitive ability. There are
several key differences between the present study and that of
Staals et al. (2015) , which might account for our differing results.
First, we were unable to include 140 of Staals’ 680 participants
due to MRI noise or motion artefacts, which precluded the quan-
tification of the computational PVS measure. As a higher burden
of imaging artefacts likely reflect poorer brain health, the range of
SVD severity is potentially reduced in our sample. The anticipated
effect of this would be a reduction in the magnitude of observed
effect sizes between SVD burden and cognitive outcomes, however
this was not the case, so our smaller, less noisy sample is unlikely
to be responsible for our differing results. Second, we used con-
tinuous as opposed to ordinal MRI data for two key SVD features
(WMH and PVS) of our total SVD burden variable. In separate
regression models, the reconstructed SVD variable used by Staals
et al. was negatively associated with all cognitive domains that
we tested, but the effect size magnitudes of these models were
significantly smaller than those using the computationally-derived
SVD score as a predictor. This suggests that incorporating con-
tinuous measurements of WMH and PVS into the original total
SVD burden score increased the fidelity of the SVD burden mea-
sure, revealing associations with cognitive outcomes which were
previously unobserved. The computationally-derived SVD variable
also demonstrated greater predictive power in its associations
with cognitive outcomes than WMH/TIV, suggesting that some of
these effects may be missed when using WMH volume as the sole
predictor of cognitive performance. Whereas tests of processing speed may be particularly sensitive
to, and possibly an early indicator of the cognitive impact of SVD
( Deary et al., 2019 ), our findings suggest that SVD burden also as-
sociates with poorer performance on tests of verbal memory and
visuospatial ability. Future research studies and clinical trials as-
sessing domain-specific cognitive outcomes in SVD should assess
all major domains of cognitive ability in order to capture a more
accurate picture of SVD-related cognitive impairments. We have
also demonstrated the benefit of constructing a computationally-
derived variable of total SVD burden, over one constructed using
visually-rated MRI data alone. A latent variable of SVD burden us-
ing continuous MRI data may be useful in a research setting for
testing associations between SVD burden and clinically-relevant
outcomes, however, further interrogation of the latent SVD bur-
den variable is required before it could be considered for use as a
marker of SVD severity in a clinical trial setting. We are yet to ex-
amine, for example, how the latent SVD variable might change over
time, or whether it can be constructed using data from clinical
populations with more substantial burden of SVD or more complex
multi-morbidities, such as Alzheimer’s disease. The consistency of
latent SVD variables using computationally-derived data might also
vary according to scanning parameters, or methods used to quan-
tify the radiological markers of SVD. 
Strengths of this study include our large sample size, extensive
cognitive testing, and detailed assessment of biomarker variables,
which enabled us to account for a broad range of vascular risk fac-
tors. Additionally, as childhood IQ accounts for approximately 50%
of the variance in cognitive ability in later life ( Deary, 2014 ), a fur-
ther strength of this study is our ability to account for this con-
found by including age-11 IQ as a covariate in our analyses. Age-11
IQ had the greatest impact of any of the covariates we included,
attenuating the standardized betas of the associations between to-
tal SVD burden and later-life cognitive abilities by an average of
about .04. Limitations of this study include our reliance on bi-
nary measurements of lacunes and microbleeds, which were used
due to the scarcity of participants in our sample with more than
one lacune or microbleed. In a sample of participants with more
substantial SVD pathology, it might be desirable to model these
variables as count data, as the reduction of highly variable data
into binary outcomes results in the loss of information. Compu-
tational continuous measures of lacunes and microbleeds are also
feasible, however, it is not yet clear whether these should be ex-
pressed as a total volume or count; microbleeds may be contam-
inated with other mineral deposits, and as the least frequent SVD
lesions, their contribution to the total SVD burden is well captured
in a binary score. A valid computational measure would likely fur-
ther increase the sensitivity of the latent SVD variable and should
be tested in future, especially in more diseased populations likely
to have more lacunes and microbleeds. A further limitation of this
study is that the computationally-derived SVD variable incorpo-
rated a measure of PVS in the centrum semiovale, whereas the re-
constructed SVD score used by Staals et al. (2015) incorporated a
measure of PVS in the basal ganglia. Whereas PVS in the centrum
semiovale are related to cerebral amyloid angiopathy (CAA) pathol-
ogy, they are also present in sporadic SVD; in the LBC1936, visual
ratings of PVS in the centrum semiovale and basal ganglia corre-
late with one another ( r = 0.40; p < 0.001) and strong associa-
tions between computational PVS count and other markers of SVD,
such as Fazekas scores and WMH volumes, have previously been
reported ( Ballerini et al., 2020 ). However, the associations that we
observed between SVD burden and cognitive ability in the domains
of processing speed, verbal memory and visuospatial ability in the
LBC1936 support the suggestion that SVD affects multiple cognitive
domains before clinical presentation. 










































































































We constructed a computationally-derived variable represent-
ing the total MRI-visible burden of SVD using continuous scores of
WMH and PVS, and binary ratings of lacunes and microbleeds. SVD
burden associated negatively with verbal memory and visuospatial
ability, but this is likely due to SVD’s association with general cog-
nitive ability. SVD burden was also negatively associated with pro-
cessing speed, but this association was found to be independent of
poorer general cognitive ability. Future research studies and clini-
cal trials monitoring cognitive outcomes in SVD should assess the
domains of memory and visuospatial ability in addition to process-
ing speed, in order to capture a fuller and more clinically-relevant
picture of SVD-related cognitive abilities. 
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